Identifying biomarkers for Alzheimer's disease
Biomarker
This study is looking for ways to identify Alzheimer's disease more clearly by using brain scans, and it's designed for older adults who may have memory or thinking issues, helping doctors better understand the disease and find better treatments.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10874740 on NIH RePORTER |
What this research studies
This research focuses on establishing reliable biomarkers that can differentiate Alzheimer's disease from other cognitive conditions in aging. Using advanced neuroimaging techniques like MRI and PET scans, the study aims to track changes in brain structure and pathological markers associated with Alzheimer's. By analyzing a diverse group of participants over time, the research seeks to enhance understanding of disease mechanisms and improve therapeutic targeting. This collaborative effort is part of a larger national network dedicated to Alzheimer's research.
Who could benefit from this research
Good fit: Ideal candidates include individuals experiencing cognitive decline or those at risk for Alzheimer's disease.
Not a fit: Patients with cognitive impairments unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and targeted treatments for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using neuroimaging to identify biomarkers for Alzheimer's, indicating a potential for success in this approach.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Whitlow, Christopher T — Wake Forest University Health Sciences
- Study coordinator: Whitlow, Christopher T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.